Pfizer, Novo and Metsera
Digest more
(Reuters) -Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a ...
Pharma giant had to pay a blockbuster price to buy Metsera after the biotech prospect spurred an auction with Novo Nordisk ...
22hon MSN
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, ...
“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...
Pfizer not only beat expectations last quarter, but also boosted its guidance.
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...
During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback